Search Within

Jane E Myers

Formats
  1. Journal Article (11)
  2. Meeting Abstract (5)
  3. Conference Paper (1)
Groups
  1. Center for Hematologic Malignancies (17)
  2. Department of Medicine (17)
  3. Hematologic Malignancies, Division of (17)
  4. Lymphoma (16)
  5. Molecular Pharmacology and Chemistry Program Faculty (11)
  6. Sloan Kettering Institute Faculty (11)

More Groups

People
  1. David Straus (15)
  2. Bayard Clarkson (8)
  3. Joachim Yahalom (8)
  4. James Caravelli (5)
  5. Carol Portlock (4)
  6. Jeffrey Gaynor (4)

More People

Years
  1. 2004 (2)
  2. 2002 (1)
  3. 2001 (1)
  4. 1998 (1)
  5. 1996 (2)
  6. 1995 (1)

More Years

Publications
  1. Blood (6)
  2. Journal of Clinical Oncology (3)
  3. Annals of Oncology (2)
  4. Cancer (2)
  5. Antibody, Immunoconjugates, and Radiopharmaceuticals (1)
  6. Leukemia and Lymphoma (1)

More Publications

Publishers
  1. American Society of Hematology (6)
  2. American Society of Clinical Oncology (3)
  3. Oxford University Press (2)
  4. Wiley Blackwell (2)
  5. Elsevier Inc. (1)
  6. Mary Ann Liebert, Inc. (1)

More Publishers

Results (17)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The NHL-15 protocol for aggressive non-Hodgkin's lymphomas: A sequential dose-dense, dose-intense regimen of doxorubicin, vincristine and high-dose cyclophosphamide
    Journal Article

    Portlock, C. S.; Qin, J.; Schaindlin, P.; Roistacher, N.; Myers, J.; Filippa, D.; Louie, D.; Zelenetz, A. D.; O'Brien, J. P.; Moskowitz, C.; more...
    Annals of Oncology (2004)

    Fulltext@MSK | Save
  • Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease
    Journal Article

    Straus, D. J.; Portlock, C. S.; Qin, J.; Myers, J.; Zelenetz, A. D.; Moskowitz, C.; Noy, A.; Goy, A.; Yahalom, J.
    Blood (2004)

    Fulltext@MSK | Save
  • Randomized study of mixed bacterial vaccine (MBV) for follicular lymphoma (FL): An evaluation over 20 years
    Meeting Abstract

    Kempin, S.; Straus, D. J.; Koziner, B.; Lee, B. J.; Mertelsmann, R. H.; Nisce, L.; Camacho, E.; Filippa, D.; Old, L.; Arlin, Z.; more...
    Blood (2002)

    Fulltext@MSK | Save
  • Results of a prospective randomized trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) alone vs. ABVD plus radiation therapy for early stage non bulky Hodgkin's disease
    Meeting Abstract

    Straus, D. J.; Yahalom, J.; Zelenetz, A. D.; Qin, J.; Myers, J.; Moskowitz, C. H.; Noy, A.; Bertino, J. R.; Portlock, C. S.
    Blood (2001)

    Fulltext@MSK | Save
  • Serial gallium scans in patients with bulky early stage Hodgkin's disease treated with chemotherapy and irradiation predict outcome
    Meeting Abstract

    Rini, J.; Yeung, H.; Macapinlac, H.; Myers, J.; Larson, S.; Yahalom, J.; Glassman, J.; Straus, D.
    Blood (1998)

    Fulltext@MSK | Save
  • A prognostic model for advanced Hodgkin's disease (HD) at M.D. Anderson (MDA) validated with an independent set of patients treated at Memorial Sloan-Kettering (MSK)
    Meeting Abstract

    Sarris, A. H.; Straus, D.; Preti, A.; Smith, T.; Myers, J.; Hess, M.; Pugh, W.; Cabanillas, F.
    Blood (1996)

    Fulltext@MSK | Save
  • Preliminary experience with paclitaxel for the treatment of relapsed and refractory Hodgkin's disease
    Journal Article

    Younes, A.; Cabanillas, F.; McLaughlin, P. W.; Hagemeister, F. B.; Farber, C.; Sarris, A.; Pate, O.; Myers, J.; Portlock, C.
    Annals of Oncology (1996)

    Fulltext@MSK | Save
  • Initial dose-intense therapy with vincristine (V), adriamycin (A) and dexamethasone (D) followed by high-dose cyclophosphamide (CY), results in high remission rates in patients with advanced myeloma (MM) with poor prognostic features
    Meeting Abstract

    Niesvizky, R.; Choy, C. G.; Siegel, D.; Straus, D.; Myers, J. E.; Heller, G.; Michaeli, J.
    Blood (1995)

    Fulltext@MSK | Save
  • Phase I dose-escalation trial of iodine 131-labeled monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma
    Journal Article

    Czuczman, M. S.; Straus, D. J.; Divgi, C. R.; Graham, M.; Garin-Chesa, P.; Finn, R.; Myers, J.; Old, L. J.; Larson, S. M.; Scheinberg, D. A.
    Journal of Clinical Oncology (1993)

    Fulltext@MSK | Save
  • Adjuvant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy after radiation therapy in stage I low‐grade and intermediate‐grade non‐Hodgkin lymphoma: Results of a prospective randomized study
    Journal Article

    Yahalom, J.; Varsos, G.; Fuks, Z.; Myers, J.; Clarkson, B. D.; Straus, D. J.
    Cancer (1993)

    Fulltext@MSK | Save